TDOC Teladoc Health, Inc.

NYSE teladochealth.com


$ 8.94 $ 0.01 (0.11 %)    

Wednesday, 15-Oct-2025 19:17:20 EDT
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 8.94
$ 8.95
$ 8.90 x 300
$ 8.98 x 4
$ 8.70 - $ 9.10
$ 6.35 - $ 15.21
8,154,569
na
1.58B
$ 1.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 10-31-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 04-26-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 10-27-2023 09-30-2023 10-Q
9 07-28-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-02-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-01-2021 09-30-2021 10-Q
17 08-02-2021 06-30-2021 10-Q
18 05-03-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 07-30-2020 06-30-2020 10-Q
22 04-29-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 10-30-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 04-30-2019 03-31-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-01-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-08-2017 03-31-2017 10-Q
35 03-01-2017 12-31-2016 10-K
36 10-27-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-03-2016 12-31-2015 10-K
40 11-02-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-teladoc-health-tdoc-stock-is-trading-higher-wednesday

Shares of Teladoc Health Inc (NYSE: TDOC) are trading higher and trending Wednesday afternoon. Here's what investors need t...

 evercore-isi-group-maintains-in-line-on-teladoc-health-raises-price-target-to-9

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and raises the price targe...

 teladoc-tdoc-shares-climb-on-bullish-commentary-from-citron-research

Shares of Teladoc Health are surging Friday morning after Citron Research posted a bullish note on the telehealth provider.

 citron-research-posts-on-x-tdoc--we-were-not-wrong-just-early-reason-for-recent-is-last-time-livongo-maus-were-this-strong-the-stock-was-15-today-its-85-even-as-bofa-just-reported-livongo-usage-55-yy-the-biggest-jump-since-jan-25--livongo-is-the-saas-backbone-of-teladoc-recurring

https://x.com/citronresearch/status/1974106818939920519?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

 teladoc-health-announces-it-has-acquired-telecare-financial-terms-not-disclosed

Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Austra...

 teladoc-health-reports-smaller-than-expected-q2-loss-revenue-tops-estimates

Teladoc announces second-quarter revenue of $631.9 million, beating analyst estimates of $623.1 million.

 teladoc-health-sees-q3-gaap-eps-035-020-vs-018-est-sees-sales-614000m-636000m-vs-628009m-est

Teladoc Health (NYSE:TDOC) is looking for Q3 GAAP EPS of $(0.35)-$(0.20) vs $(0.18) analyst estimate. sees sales of $614.000 mi...

 teladoc-health-narrows-fy2025-gaap-eps-guidance-from-140-090-to-135-100-vs-108-est-narrows-fy2025-sales-guidance-from-2468b-2576b-to-2501b-2548b-vs-2517b-est

Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.40)-$(0.90) to $(1.35)-$(1.00) vs $(1.08) analyst estimate...

 teladoc-health-q2-eps-019-beats-025-estimate-sales-631900m-beat-623096m-estimate

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.25) ...

 mizuho-initiates-coverage-on-teladoc-health-with-neutral-rating-announces-price-target-of-10

Mizuho analyst Steven Valiquette initiates coverage on Teladoc Health (NYSE:TDOC) with a Neutral rating and announces Price ...

 teladoc-health-unveils-wellbound-eap-to-deliver-seamless-whole-person-support-for-us-employers-and-health-plans

The new program, purpose-built for the company's employer and health plan clients in the U.S., leverages Teladoc Health'...

 evercore-isi-group-maintains-in-line-on-teladoc-health-raises-price-target-to-8

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and raises the price targe...

 teladoc-health-stock-jumps-after-citron-research-calls-it-a-coiled-spring

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its X...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION